Royal Preston Hospital Lancashire Teaching Hospitals NHS Foundation Trust

Preston PR2 9HT

3 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer Stage II, Colorectal Cancer Stage III, Extensive-stage Small-cell Lung Cancer, Metastatic Head and Neck Cancer, Non-small Cell Lung Cancer, Recurrent Head and Neck Cancer, Small-cell Lung Cancer, Unresectable Head and Neck Squamous Cell Carcinoma

Studies at this site

• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer — Running, not enrolling
• Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy — Running, not enrolling